Children with islet autoimmunity and enterovirus infection demonstrate a distinct cytokine profile

Diabetes

Volumn 61, Issue 6, 2012, Pages 1500-1508

  Yeung, Wing Chi G ^a   Al Shabeeb, Ammira ^a,b   Pang, Chi Nam Ignatius ^a   Wilkins, Marc R ^a   Catteau, Jacki ^b,c   Howard, Neville J ^c   Rawlinson, William D ^a,b   Craig, Maria E ^a,c,d  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

^c CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; EOTAXIN 3; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 16; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 20; INTERLEUKIN 21; INTERLEUKIN 28A; INTERLEUKIN 5; INTERLEUKIN 7; MONOCYTE CHEMOTACTIC PROTEIN 4; THROMBOPOIETIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; AUTOIMMUNITY; CHILD; CONTROLLED STUDY; ENTEROVIRUS INFECTION; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PANCREAS ISLET AUTOIMMUNITY; PANCREAS ISLET DISEASE; PRESCHOOL CHILD; PRIORITY JOURNAL;

AUTOIMMUNITY; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; CYTOKINES; DIABETES MELLITUS, TYPE 1; ENTEROVIRUS INFECTIONS; FEMALE; HUMANS; INFANT; MALE; PREDIABETIC STATE; PROSPECTIVE STUDIES;

EID: 84861881141     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db11-0264     Document Type: Article

References (45)

1. Rowe PA, Campbell-Thompson ML, Schatz DA, Atkinson MA. The pancreas in human type 1 diabetes. Semin Immunopathol 2011;33:29-43
2. Eizirik DL, Colli ML, Ortis F. The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat Rev Endocrinol 2009;5:219-226
3. Hanifi-Moghaddam P, Kappler S, Seissler J, et al. Altered chemokine levels in individuals at risk of type 1 diabetes mellitus. Diabet Med 2006;23:156-163
4. Stechova K, Bohmova K, Vrabelova Z, et al. High T-helper-1 cytokines but low T-helper-3 cytokines, inflammatory cytokines and chemokines in children with high risk of developing type 1 diabetes. Diabetes Metab Res Rev 2007;23:462-471 (Pubitemid 47520903)
5. Erlich H, Valdes AM, Noble J, et al.; Type 1 Diabetes Genetics Consortium. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes 2008;57:1084-1092
6. Hermann R, Knip M, Veijola R, et al.; FinnDiane Study Group. Temporal changes in the frequencies of HLA genotypes in patients with type 1 diabetes-indication of an increased environmental pressure? Diabetologia 2003;46:420-425 (Pubitemid 36547599)
7. Fourlanos S, Varney MD, Tait BD, et al. The rising incidence of type 1 diabetes is accounted for by cases with lower-risk human leukocyte antigen genotypes. Diabetes Care 2008;31:1546-1549
8. Catanzariti L, Faulks K, Moon L, Waters AM, Flack J, Craig ME. Australia's national trends in the incidence of type 1 diabetes in 0-14-year-olds, 2000-2006. Diabet Med 2009;26:596-601
9. Patterson CC, Dahlquist GG, Gyürüs E, Green A, Soltész G; EURODIAB Study Group. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 2009;373:2027-2033
10. Roivainen M, Rasilainen S, Ylipaasto P, et al. Mechanisms of Coxsackievirusinduced damage to human pancreatic beta-cells. J Clin Endocrinol Metab 2000;85:432-440 (Pubitemid 32268847)
11. Oikarinen M, Tauriainen S, Honkanen T, et al. Analysis of pancreas tissue in a child positive for islet cell antibodies. Diabetologia 2008;51:1796-1802
12. Yeung WC, Rawlinson WD, Craig ME. Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies. BMJ 2011;342:d35
13. Filippi CM, Estes EA, Oldham JE, von Herrath MG. Immunoregulatory mechanisms triggered by viral infections protect from type 1 diabetes in mice. J Clin Invest 2009;119:1515-1523
14. Hober D, Sauter P. Pathogenesis of type 1 diabetes mellitus: interplay between Enterovirus and host. Nat Rev Endocrinol 2010;6:279-289
15. Honkanen J, Nieminen JK, Gao R, et al. IL-17 immunity in human type 1 diabetes. J Immunol 2010;185:1959-1967
16. Chatzigeorgiou A, Harokopos V, Mylona-Karagianni C, Tsouvalas E, Aidinis V, Kamper EF. The pattern of inflammatory/anti-inflammatory cytokines and chemokines in type 1 diabetic patients over time. Ann Med 2010;42:426-438
17. Roep BO, Kleijwegt FS, van Halteren AG, et al. Islet inflammation and CXCL10 in recent-onset type 1 diabetes. Clin Exp Immunol 2010;159:338-343
18. McIver CJ, Jacques CF, Chow SS, et al. Development of multiplex PCRs for detection of common viral pathogens and agents of congenital infections. J Clin Microbiol 2005;43:5102-5110 (Pubitemid 41484012)
19. Craig ME, Robertson P, Howard NJ, Silink M, Rawlinson WD. Diagnosis of Enterovirus infection by genus-specific PCR and enzyme-linked immunosorbent assays. J Clin Microbiol 2003;41:841-844 (Pubitemid 36184211)
20. Harnaha J, Machen J, Wright M, et al. Interleukin-7 is a survival factor for CD4+ CD25+ T-cells and is expressed by diabetes-suppressive dendritic cells. Diabetes 2006;55:158-170 (Pubitemid 43343311)
21. Cheatem D, Ganesh BB, Gangi E, Vasu C, Prabhakar BS. Modulation of dendritic cells using granulocyte-macrophage colony-stimulating factor (GM-CSF) delays type 1 diabetes by enhancing CD4+CD25+ regulatory T cell function. Clin Immunol 2009;131:260-270
22. Karlsson MG, Lawesson SS, Ludvigsson J. Th1-like dominance in high-risk first-degree relatives of type I diabetic patients. Diabetologia 2000;43:742-749 (Pubitemid 30409150)
23. Durinovic-Belló I, Riedl M, Rosinger S, et al. Th2 dominance of T helper cell response to preproinsulin in individuals with preclinical type 1 diabetes. Ann N Y Acad Sci 2002;958:209-213 (Pubitemid 34592229)
24. Nicoletti F, Conget I, Di Mauro M, et al. Serum concentrations of the interferon-gamma-inducible chemokine IP-10/CXCL10 are augmented in both newly diagnosed type I diabetes mellitus patients and subjects at risk of developing the disease. Diabetologia 2002;45:1107-1110 (Pubitemid 34985286)
25. Antonelli A, Fallahi P, Ferrari SM, et al. Serum Th1 (CXCL10) and Th2 (CCL2) chemokine levels in children with newly diagnosed type 1 diabetes: a longitudinal study. Diabet Med 2008;25:1349-1353
26. Hussain MJ, Peakman M, Gallati H, et al. Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM. Diabetologia 1996;39:60-69 (Pubitemid 26029733)
27. Lehuen A, Diana J, Zaccone P, Cooke A. Immune cell crosstalk in type 1 diabetes. Nat Rev Immunol 2010;10:501-513
28. Trembleau S, Penna G, Gregori S, Giarratana N, Adorini L. IL-12 administration accelerates autoimmune diabetes in both wild-type and IFN-γ deficient nonobese diabetic mice, revealing pathogenic and protective effects of IL-12-induced IFN-g. J Immunol 2003;170:5491-5501 (Pubitemid 36617837)
29. Yoon JW, Jun HS. Autoimmune destruction of pancreatic beta cells. Am J Ther 2005;12:580-591
30. Meagher C, Beilke J, Arreaza G, et al. Neutralization of interleukin-16 protects nonobese diabetic mice from autoimmune type 1 diabetes by a CCL4-dependent mechanism. Diabetes 2010;59:2862-2871
31. Bettelli E, Korn T, Kuchroo VK. Th17: the third member of the effector T cell trilogy. Curr Opin Immunol 2007;19:652-657 (Pubitemid 350236805)
32. Marwaha AK, Crome SQ, Panagiotopoulos C, et al. Cutting edge: Increased IL-17-secreting T cells in children with new-onset type 1 diabetes. J Immunol 2010;185:3814-3818
33. Wei CC, Hsu YH, Li HH, et al. IL-20: biological functions and clinical implications. J Biomed Sci 2006;13:601-612
34. Barrett JC, Clayton DG, Concannon P, et al.; Type 1 Diabetes Genetics Consortium. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 2009;41:703-707
35. Witte K, Witte E, Sabat R, Wolk K. IL-28A, IL-28B, and IL-29: promising cytokines with type I interferon-like properties. Cytokine Growth Factor Rev 2010;21:237-251
36. Elfaitouri A, Berg AK, Frisk G, Yin H, Tuvemo T, Blomberg J. Recent Enterovirus infection in type 1 diabetes: evidence with a novel IgM method. J Med Virol 2007;79:1861-1867 (Pubitemid 350006311)
37. Zaccone P, Phillips J, Conget I, et al. Interleukin-13 prevents autoimmune diabetes in NOD mice. Diabetes 1999;48:1522-1528 (Pubitemid 29356858)
38. Calzascia T, Pellegrini M, Lin A, et al. CD4 T cells, lymphopenia, and IL-7 in a multistep pathway to autoimmunity. Proc Natl Acad Sci U S A 2008;105: 2999-3004 (Pubitemid 351723657)
39. Spolski R, Kashyap M, Robinson C, Yu Z, Leonard WJ. IL-21 signaling is critical for the development of type I diabetes in the NOD mouse. Proc Natl Acad Sci U S A 2008;105:14028-14033
40. Johnson LD, Jameson SC. Immunology. A chronic need for IL-21. Science 2009;324:1525-1526
41. O'Garra A, Murphy KM. From IL-10 to IL-12: how pathogens and their products stimulate APCs to induce T(H)1 development. Nat Immunol 2009; 10:929-932
42. Gu R, Shampang A, Reilly A, Fisher D, Glass W, Ramsingh AI. IL-10 is pathogenic during the development of Coxsackievirus B4-induced chronic pancreatitis. Virology 2009;395:77-86
43. Nair S, Leung KC, Rawlinson WD, Naing Z, Craig ME. Enterovirus infection induces cytokine and chemokine expression in insulin-producing cells. J Med Virol 2010;82:1950-1957
44. Ylipaasto P, Kutlu B, Rasilainen S, et al. Global profiling of Coxsackievirusand cytokine-induced gene expression in human pancreatic islets. Diabetologia 2005;48:1510-1522 (Pubitemid 41175504)
45. Olsson A, Johansson U, Korsgren O, Frisk G. Inflammatory gene expression in Coxsackievirus B-4-infected human islets of Langerhans. Biochem Biophys Res Commun 2005;330:571-576 (Pubitemid 40417683)